Biotech · Private company · Boston, MA, US
Astria Therapeutics, Inc.
SEC CIK 0001454789
Track this companyFree. Adds Astria Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials75 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- navenibartPhase 3 · Hereditary Angioedema (HAE)ClinicalTrials.gov · fetched Nov 12, 2026
- NavenibartPhase 2 · Hereditary AngioedemaClinicalTrials.gov · fetched Nov 12, 2026
- STAR-0215Phase 2 · Hereditary AngioedemaClinicalTrials.gov · fetched Nov 12, 2026
- AutoinjectorPhase 1 · Healthy Adult ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- STAR-0215 (IV)Phase 1 · Hereditary AngioedemaClinicalTrials.gov · fetched Nov 12, 2026
- STAR-0215 (SC)Phase 1 · Hereditary AngioedemaClinicalTrials.gov · fetched Nov 12, 2026
- STAR-0310Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- Vial and syringePhase 1 · Healthy Adult ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy ParticipantsPHASE1 · RECRUITING · started Apr 21, 2026ClinicalTrials.gov NCT07635095 · fetched Nov 12, 2026
- A Long-Term Study of Navenibart in Participants With Hereditary AngioedemaPHASE3 · ENROLLING_BY_INVITATION · started Oct 1, 2025ClinicalTrials.gov NCT07204938 · fetched Nov 12, 2026
- A Study of Navenibart in Participants With Hereditary AngioedemaPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 20, 2025ClinicalTrials.gov NCT06842823 · fetched Nov 12, 2026
- A Study of STAR-0310 in Healthy Adult ParticipantsPHASE1 · ACTIVE_NOT_RECRUITING · started Jan 7, 2025ClinicalTrials.gov NCT06782477 · fetched Nov 12, 2026
- A Long-term Study of STAR-0215 in Participants With Hereditary AngioedemaPHASE2 · ACTIVE_NOT_RECRUITING · started Sep 26, 2023ClinicalTrials.gov NCT06007677 · fetched Nov 12, 2026
- A Study of Navenibart (STAR-0215) in Participants With Hereditary AngioedemaPHASE1_PHASE2 · COMPLETED · started Feb 21, 2023ClinicalTrials.gov NCT05695248 · fetched Nov 12, 2026
- A Study of STAR-0215 in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Jul 27, 2022ClinicalTrials.gov NCT05477160 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Jan 23, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jan 21, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Dec 23, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 14, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 12, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 6, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 12, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 13, 2025 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 11, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 11, 2025 · fetched Nov 12, 2026